The US Supreme Court on Thursday ruled in favor of the former Monsanto company in a closely watched case that limits people’s ability to sue pesticide companies for alleged illnesses or injuries. TNL editor-in-chief Carey Gillam talks to George Kimbrell of the Center for Food Safety about the decision.
The New Lede Editor-in-Chief Carey Gillam talked with attorney and consumer advocate Whitney di Bona from Drugwatch about a flurry of recent legal maneuvers in the battle over Bayer’s proposed $7.25 billion class action settlement of Roundup litigation.
US and European regulators should take urgent action to more tightly regulate glyphosate, the world’s most widely used weed killer, in light of strong scientific evidence that the pesticide can cause cancer and other health problems, a group of international scientists said last week at a symposium in Seattle.
A new analysis links high use of the weed killer glyphosate to elevated rates of non-Hodgkin lymphoma (NHL), particularly in the Upper Midwest, reinforcing years of research linking cancer to the weed killer made popular by Monsanto.
Bayer’s proposed $7.25 billion class action settlement of Roundup litigation received preliminary approval from a Missouri court on Wednesday, rejecting opposition from a group of lawyers representing roughly 20,000 plaintiffs who claim they developed cancer from using the company’s herbicide products.
Wherever Trump looks, he sees existential threats to America that do not exist. He invents fantasy crises as a pretext to exercise emergency powers, like the emergency tariffs just invalidated by the Supreme Court.
A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer’s proposed class action settlement of Roundup litigation, citing concerns that the settlement deal will not be fair to cancer victims.
In an opening salvo aimed at convincing the US Supreme Court to curtail costly Roundup litigation, Bayer is citing support from President Donald Trump and US regulators while renewing a threat to stop sales of glyphosate-based herbicides to farmers if it does not prevail with the justices.
Bayer has announced a proposed $7.25 billion class action settlement to address tens of thousands of U.S. lawsuits claiming its Roundup weedkiller caused cancer — including future cases. The deal must still be approved by the court and ties into a key Supreme Court fight over weedkiller warnings.
US regulators are dismissing new research by international cancer experts that warns of links between cancer and the widely used pesticide atrazine, deriding the team of cancer scientists and echoing atrazine maker Syngenta in its criticism.